NAVDEEP SOOD: Open Payments
NPI 1043231830 · GRAND ISLAND, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$25,356 in 90 payments from 7 companies in 2025. Trend: 2023 $10,363 · 2024 $13,158 · 2025 $25,356
Honoraria: $13,750Speaker / faculty: $8,500Food & beverage: $1,680Travel & lodging: $1,324Education: $101
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 21 | $15,830 |
| ABBVIE INC. | 35 | $8,960 |
| Teva Pharmaceuticals USA, Inc. | 27 | $389 |
| E.R. Squibb & Sons, L.L.C. | 2 | $68 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| Neurocrine BioSciences, Inc. | 2 | $43 |
| Alkermes, Inc. | 1 | $18 |
Products named: Auvelity, VRAYLAR, UZEDY, AUSTEDO XR, COBENFY, REXULTI, INGREZZA, ARISTADA.
Industry payments across NE — which companies pay providers there.
